A detailed history of Allspring Global Investments Holdings, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 204,987 shares of CDNA stock, worth $4.94 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
204,987
Previous 21,164 868.56%
Holding current value
$4.94 Million
Previous $328,000 1850.91%
% of portfolio
0.01%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$14.41 - $33.99 $2.65 Million - $6.25 Million
183,823 Added 868.56%
204,987 $6.4 Million
Q2 2024

Jul 26, 2024

BUY
$7.56 - $16.15 $18,922 - $40,423
2,503 Added 13.41%
21,164 $328,000
Q1 2024

Apr 18, 2024

BUY
$7.96 - $12.37 $147,108 - $228,609
18,481 Added 10267.22%
18,661 $197,000
Q4 2023

Jan 25, 2024

SELL
$4.9 - $12.86 $56,266 - $147,671
-11,483 Reduced 98.46%
180 $2,000
Q3 2023

Oct 27, 2023

BUY
$7.0 - $11.26 $81,641 - $131,325
11,663 New
11,663 $81,000
Q2 2023

Jul 18, 2023

BUY
$7.61 - $9.46 $28,590 - $35,541
3,757 Added 23.91%
19,467 $165,000
Q1 2023

Apr 13, 2023

BUY
$8.83 - $17.61 $116,926 - $233,191
13,242 Added 536.55%
15,710 $143,000
Q4 2022

Jan 23, 2023

SELL
$10.88 - $20.05 $587 - $1,082
-54 Reduced 2.14%
2,468 $0
Q3 2022

Oct 26, 2022

SELL
$16.06 - $26.39 $1.51 Million - $2.48 Million
-94,021 Reduced 97.39%
2,522 $42,000
Q2 2022

Jul 25, 2022

SELL
$20.49 - $39.72 $550,832 - $1.07 Million
-26,883 Reduced 21.78%
96,543 $2.07 Million
Q1 2022

May 02, 2022

SELL
$28.19 - $46.6 $4.13 Million - $6.83 Million
-146,540 Reduced 54.28%
123,426 $4.57 Million
Q4 2021

Jan 28, 2022

BUY
$41.2 - $73.6 $11.1 Million - $19.9 Million
269,966 New
269,966 $12.3 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.29B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.